Skip to content

Clinical trials

Ischemic Stroke trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Country / region: Russia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20112
20122
20141
20152
20162
20171
20184
20192
20201
20211
20225
20233
20247
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting11
Unknown status6
Enrolling by invitation2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pharmasoft4
Clinical Institute of the Brain, Russia3
POLYSAN Scientific & Technological Pharmaceutical Company3
Supergene, LLC3
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health2
Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine2
Pirogov Russian National Research Medical University2
Bayer1
Bristol-Myers Squibb1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke39
Stroke16
Atherosclerosis2
Atrial Fibrillation2
Brain Ischemia2
COVID-192
Carotid Artery Diseases2
Cerebrovascular Disorders2
Cognitive Dysfunction2
Hemorrhagic Stroke2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.